The CMV trials seem to have experienced another setback, as announced via their most recent newsletter last week (excerpt below).
I have to hand it to them though, they're staying on message. The Telegraph article is from Dec. 2000, so they've been pitching the same story for close to two decades now.
"We have a disappointing announcement to make:
GMP manufacture of the second component of the vaccine - by IDT in Germany - has been subject to a delay. The delay has come not as a result of any problems or difficulties with the manufacture process but because IDT have taken a decision to give priority to one of their other vaccine projects. This delay has put back the estimated start date of the Phase I trial from Sept to Dec 2016, which in turn puts back the start date of the Phase IIa trial. The new timeline is illustrated in the Gantt chart below."